Similarly, miR-218 suppress cancer progression by targeting the 3’-UTR regions of CDK6 and cyclin D1, as demonstrated in gastric cancer studies, indicating a possible analogous mechanism in breast cancer (58). Here, CDK6 is linked to cancer.